Stijn Keereweer

Papers

1

Total Citations

84

H-Index

1

About

Stijn Keereweer is a leading surgical oncologist and researcher whose work centers on advancing minimally invasive colorectal surgery through intraoperative imaging. His primary research focus is the use of near-infrared fluorescence imaging with indocyanine green (ICG) to assess bowel perfusion in real time, a technique designed to reduce the risk of anastomotic leakage—a severe complication following colorectal resection. Keereweer’s most impactful contribution is the landmark AVOID trial, a multicentre, randomised, controlled phase 3 study published in 2024, which demonstrated that ICG fluorescence angiography significantly lowers anastomotic leakage rates in minimally invasive colorectal surgery. This work, already cited over 80 times, has provided high-level evidence for a practice-changing technology, directly improving patient outcomes by enabling surgeons to make more informed intraoperative decisions. Beyond this trial, Keereweer has published extensively on fluorescence-guided surgery, contributing to the broader field of image-guided oncology. His research bridges the gap between technological innovation and clinical application, making him a key figure in the evolution of safer, more precise surgical techniques.

Research Focus

Key Achievements

1
H-Index
1
Papers
84
Total Citations
84
Avg Citations/Paper
🏆 Most Cited Paper
Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trial
84 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 31

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago